Keyphrases
Putative Drug Targets
100%
Estrogen Receptor β
100%
Triple-negative Breast Cancer
100%
Breast Cancer Treatment
25%
Gene Expression
12%
Possible Mechanisms
12%
Quantitative PCR
12%
Xenograft
12%
Antitumor Activity
12%
Cancer Metastasis
12%
Cells in Culture
12%
Gene Expression Analysis
12%
RNA Sequencing (RNA-seq)
12%
Progesterone Receptor
12%
Breast Cancer Patients
12%
Human Epidermal Growth Factor Receptor 2 (HER2)
12%
Estrogen Receptor 1 (ESR1)
12%
Patient Outcomes
12%
Epithelial-to-mesenchymal Transition
12%
Preclinical Animal Models
12%
Tumor Metastasis
12%
Suppressive Activity
12%
Human Triple Negative Breast Cancer
12%
Metastasizing
12%
Breast Cancer Mortality
12%
Breast Cancer Growth
12%
Metastatic Breast Cancer
12%
Selective Agonist
12%
Difficult-to-treat
12%
Breast Cancer Cases
12%
Cancer Invasiveness
12%
Primary Tumor Growth
12%
Aggressive Subtypes
12%
Distant Organ
12%
Cancer Cell Invasiveness
12%
Triple-negative Breast Cancer Cells
12%
Transition Marker
12%
Breast Cancer Subtypes
12%
Agonist Ligands
12%
Breast Cancer Stem Cell Markers
12%
ESR2 Gene
12%
Medicine and Dentistry
Triple Negative Breast Cancer
100%
Estrogen Receptor Beta
100%
Breast Cancer
41%
Metastatic Carcinoma
25%
Cancer Cell
16%
Cancer Therapy
16%
Gene Expression Profiling
8%
Cell Marker
8%
Epileptic Absence
8%
Tumor Progression
8%
Real-Time Polymerase Chain Reaction
8%
Cancer Growth
8%
Cancer Mortality
8%
Primary Tumor
8%
Mesenchymal-Epithelial Transition
8%
Xenograft
8%
Cell Invasion
8%
RNA Sequencing
8%
Antineoplastic Activity
8%
Progesterone Receptor
8%
Estrogen Receptor Alpha
8%
Cancer Stem Cell
8%
Pharmacology, Toxicology and Pharmaceutical Science
Estrogen Receptor Beta
100%
Triple Negative Breast Cancer
100%
Breast Cancer
41%
Metastasis
16%
Malignant Neoplasm
8%
Mouse Model
8%
Antitumor Activity
8%
Tumor Growth
8%
Epileptic Absence
8%
Progesterone Receptor
8%
Estrogen Receptor Alpha
8%
Primary Tumor
8%
Cancer Growth
8%
Cancer Mortality
8%
Cell Marker
8%
Biochemistry, Genetics and Molecular Biology
Estrogen Receptor Beta
100%
Cancer Cell
25%
Gene Expression Profiling
12%
Agonist
12%
Isoform
12%
RNA Sequencing
12%
Real-Time Polymerase Chain Reaction
12%
Tumor Progression
12%
Mesenchymal-Epithelial Transition
12%
Estrogen Receptor Alpha
12%
Antineoplastic Activity
12%
Mouse Model
12%
Cell Invasion
12%
Cancer Mortality
12%
Progesterone Receptor
12%
Stem Cell Marker
12%
Cancer Stem Cell
12%